Pen BP-48 Dual-CillinTM — veterinary medication

Overview

Source: Animal Drugs @ FDA

Proprietary name

Pen BP-48 Dual-CillinTM

Active ingredient

Penicillin G Benzathine Penicillin G Procaine

Application type

NADA

Sponsor

Huvepharma EOOD

Applications on record

1

First published

January 11, 2023

Adverse event reports

Source: openFDA VeDDRA

589

Reports mentioning this ingredient

June 2, 1987 – October 7, 2025

43

Classified serious

per reporter assessment

7

Lack of expected efficacy

resistance signal

4

Human operator exposure

needle-stick or splash

Not a risk measure. Veterinary adverse event reports are influenced by how many animals are treated, reporting practice and product age. Reports do not establish that the product caused the event, and a single report can cover an entire herd or flock. Attribution here is by active ingredient because the source dataset redacts brand names.

Attributed by active ingredient “PENICILLIN G PROCAINE”. Green Book ingredient names and VeDDRA ingredient names do not always agree exactly, so attribution is approximate and labelled as such.

Reported reactions

Source: openFDA VeDDRA

Clinical signs coded in the VICH VeDDRA four-level hierarchy, most frequent first.

Reaction terms reported for this ingredient, by report count.
Reaction (VeDDRA term)	Reports	Relative frequency
Suspension, Abnormal	137
Death	124
Anaphylaxis	73
Collapse (see also 'Cardio-vascular' and 'Systemic disorders')	43
Residues in milk	28
Injection site swelling	25
Hyperactivity	24
Vomiting	21
Injection site abscess	21
Shaking	18
Respiratory distress	17
Injection site pain	16
Dyspnoea	16
Ataxia	14
Convulsion	12
Urticaria	12
Fever	11
Product Defect, General	11
Restlessness	10
Anorexia	10

Species affected

Source: openFDA VeDDRA

Cattle 114 Horse 97 Dog 79 Pig 40 Cat 15 Goat 6 Sheep 6 Human 5 Other 3 Alpaca 1 Llama 1 Chicken 1

Regulatory context

New Animal Drug Application (NADA). A pioneer approval evaluated for target animal safety, therapeutic effectiveness, manufacturing controls and — for food-producing species — human food safety including residue depletion.

Extra-label use in food-producing animals is governed by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) and 21 CFR Part 530. It requires a valid veterinarian-client-patient relationship and is prohibited outright for certain drug classes. Withdrawal times are determined by FARAD, not by this index.

Sources for this page

Animal Drugs @ FDA	FDA CVM	Applications, sponsor, status, withdrawal
Animal & Veterinary Events	FDA CVM	VeDDRA adverse event aggregates by active ingredient